Found: 72
Select item for more details and to access through your institution.
Novel Antiretroviral Agents.
- Published in:
- Current HIV/AIDS Reports, 2020, v. 17, n. 2, p. 118, doi. 10.1007/s11904-020-00486-2
- By:
- Publication type:
- Article
Current and Future PrEP Medications and Modalities: On-demand, Injectables, and Topicals.
- Published in:
- Current HIV/AIDS Reports, 2019, v. 16, n. 4, p. 349, doi. 10.1007/s11904-019-00450-9
- By:
- Publication type:
- Article
Long term surgical outcomes for infective endocarditis in people who inject drugs: a systematic review and meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Antiretroviral Therapy: Racial Disparities among Publicly Insured Californians with HIV.
- Published in:
- Journal of Health Care for the Poor & Underserved, 2017, v. 28, n. 1, p. 406, doi. 10.1353/hpu.2017.0031
- By:
- Publication type:
- Article
HIV Preexposure Prophylaxis-The Role of Primary Care Clinicians in Ending the HIV Epidemic.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Optimizing Delivery of Preexposure Prophylaxis--The Next Frontier.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.
- Published in:
- JAMA: Journal of the American Medical Association, 2020, v. 324, n. 16, p. 1651, doi. 10.1001/jama.2020.17025
- By:
- Publication type:
- Article
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Availability of HIV Postexposure Prophylaxis Services in Los Angeles County.
- Published in:
- Clinical Infectious Diseases, 2009, v. 48, n. 11, p. 1624, doi. 10.1086/598976
- By:
- Publication type:
- Article
Quality of Care for HIV/AIDS and for Primary Prevention by HIV Specialists and Nonspecialists.
- Published in:
- AIDS Patient Care & STDs, 2016, v. 30, n. 9, p. 395, doi. 10.1089/apc.2016.0170
- By:
- Publication type:
- Article
Bone changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG A5305.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Where Is the Opioid Use Epidemic in Mexico? A Cautionary Tale for Policymakers South of the US–Mexico Border.
- Published in:
- American Journal of Public Health, 2019, v. 109, n. 1, p. 73, doi. 10.2105/AJPH.2018.304767
- By:
- Publication type:
- Article
Results from the post-exposure prophylaxis pilot program (P-QUAD) demonstration project in Los Angeles County.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Perceptions of and intentions to adopt HIV pre-exposure prophylaxis among black men who have sex with men in Los Angeles.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County.
- Published in:
- PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0262926
- By:
- Publication type:
- Article
Phase II Study of Vicriviroc versus Efavirenz (both with Zidovudine/Lamivudine) in Treatment-Naive Subjects with HIV-1 Infection.
- Published in:
- Journal of Infectious Diseases, 2008, v. 198, n. 8, p. 1113, doi. 10.1086/592052
- By:
- Publication type:
- Article
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
- Published in:
- PLoS Medicine, 2018, v. 15, n. 11, p. 1, doi. 10.1371/journal.pmed.1002690
- By:
- Publication type:
- Article
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
- Published in:
- PLoS Medicine, 2018, v. 15, n. 11, p. 1, doi. 10.1371/journal.pmed.1002690
- By:
- Publication type:
- Article
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.
- Published in:
- JAMA Pediatrics, 2017, v. 171, n. 11, p. 1063, doi. 10.1001/jamapediatrics.2017.2007
- By:
- Publication type:
- Article
Quantifying the reduction in sexual transmission of HIV-1 among MSM by early initiation of ART: A mathematical model.
- Published in:
- PLoS ONE, 2020, v. 15, n. 7, p. 1, doi. 10.1371/journal.pone.0236032
- By:
- Publication type:
- Article
A Novel Combination HIV Prevention Strategy: Post-Exposure Prophylaxis with Contingency Management for Substance Abuse Treatment Among Methamphetamine-Using Men Who Have Sex with Men.
- Published in:
- AIDS Patient Care & STDs, 2012, v. 26, n. 6, p. 320, doi. 10.1089/apc.2011.0432
- By:
- Publication type:
- Article
Sexual Risk Behaviors and Acceptability of HIV Pre-Exposure Prophylaxis Among HIV-Negative Gay and Bisexual Men in Serodiscordant Relationships: A Mixed Methods Study.
- Published in:
- AIDS Patient Care & STDs, 2012, v. 26, n. 2, p. 87, doi. 10.1089/apc.2011.0283
- By:
- Publication type:
- Article
Low incidence and prevalence of hepatitis C in two cohorts of HIV pre‐exposure prophylaxis adherence interventions in men who have sex with men in Southern California.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 7, p. 529, doi. 10.1111/jvh.13678
- By:
- Publication type:
- Article
Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States : A Cost-Effectiveness Analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Factors associated with repeat rectal Neisseria gonorrhoeae and Chlamydia trachomatis screening following inconclusive nucleic acid amplification testing: A potential missed opportunity for screening.
- Published in:
- PLoS ONE, 2019, v. 14, n. 12, p. 1, doi. 10.1371/journal.pone.0226413
- By:
- Publication type:
- Article
Mathematical modeling of HIV-1 transmission risk from condomless anal intercourse in HIV-infected MSM by the type of initial ART.
- Published in:
- PLoS ONE, 2019, v. 14, n. 7, p. 1, doi. 10.1371/journal.pone.0219802
- By:
- Publication type:
- Article
Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 2, p. 402, doi. 10.1093/cid/ciad566
- By:
- Publication type:
- Article
Self-Assessed Severity as a Determinant of Coronavirus Disease 2019 Symptom Specificity: A Longitudinal Cohort Study.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e1180, doi. 10.1093/cid/ciac129
- By:
- Publication type:
- Article
Changes in Bone Mass After Discontinuation of Preexposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 4, p. 687, doi. 10.1093/cid/ciz486
- By:
- Publication type:
- Article
Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus–uninfected Individuals in HPTN 077.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 2, p. 319, doi. 10.1093/cid/ciz439
- By:
- Publication type:
- Article
HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 12, p. 2170, doi. 10.1093/infdis/jiac415
- By:
- Publication type:
- Article
Assessing the Role of Long-Acting Cabotegravir Preexposure Prophylaxis of Human Immunodeficiency Virus: Opportunities and Aspirations.
- Published in:
- 2021
- By:
- Publication type:
- editorial
Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Long-Acting Injectable Preexposure Prophylaxis for HIV Prevention in South Africa: Is There a Will and a Way?
- Published in:
- 2016
- By:
- Publication type:
- commentary
Benefits of PrEP as an Adjunctive Method of HIV Prevention During Attempted Conception Between HIV-uninfected Women and HIV-infected Male Partners.
- Published in:
- 2015
- By:
- Publication type:
- journal article
PrEP Nonadherence, White Coat Dosing, and HIV Risk Among a Cohort of MSM.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 8, p. 1, doi. 10.1093/ofid/ofaa329
- By:
- Publication type:
- Article
Differentiating Nonoccupational Postexposure Prophylaxis Seroconverters and Non-Seroconverters in a Community-Based Clinic in Los Angeles, California.
- Published in:
- Open Forum Infectious Diseases, 2017, v. 4, n. 2, p. 1, doi. 10.1093/ofid/ofx061
- By:
- Publication type:
- Article
Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia.
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 3, p. 1, doi. 10.1093/ofid/ofv085
- By:
- Publication type:
- Article
Contingency Management Facilitates the Use of Postexposure Prophylaxis Among Stimulant-Using Men Who Have Sex With Men.
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 1, p. 1, doi. 10.1093/ofid/ofu114
- By:
- Publication type:
- Article
Engagement with HIV and COVID-19 prevention: a national cross-sectional analysis of users on a geosocial networking app.
- Published in:
- Journal of Medical Internet Research, 2022, v. 24, n. 9, p. N.PAG, doi. 10.2196/38244
- By:
- Publication type:
- Article
Evaluating group-sequential non-inferiority clinical trials following interim stopping: The HIV Prevention Trials Network 083 trial.
- Published in:
- Clinical Trials, 2022, v. 19, n. 6, p. 605, doi. 10.1177/17407745221118371
- By:
- Publication type:
- Article
Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV.
- Published in:
- Global Health: Science & Practice, 2023, v. 11, n. 2, p. 1, doi. 10.9745/GHSP-D-22-00401
- By:
- Publication type:
- Article
PRE-EXPOSURE PROPHYLAXIS PRODUCT CHOICE IN US PARTICIPANTS IN HPTN 083.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 397
- By:
- Publication type:
- Article
BONE DENSITY CHANGES WITH CAB-LA OR TDF/FTC PrEP IN MSM AND TGW IN HPTN 083.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 395
- By:
- Publication type:
- Article
CABOTEGRAVIR FOR HIV PrEP IN US BLACK MEN AND TRANSGENDER WOMEN WHO HAVE SEX WITH MEN.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 66
- By:
- Publication type:
- Article
THE LEVI SYNDROME: CHARACTERISTICS OF EARLY HIV INFECTION WITH CABOTEGRAVIR FOR PrEP.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 66
- By:
- Publication type:
- Article